Development of building projects
XPANDIR SCANDINAVIA AS
Revenue 2025
NOK 6.6m
Operating profit
NOK 3.6m
Equity
NOK 12.0m
Incorporated
2021
Share capital
NOK 50,000
Roles
Daglig lederTerje Andre Skulbru
Regnskapsfører
Styrets lederTerje Andre Skulbru
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| TERJE ANDRE SKULBRU | 100.0% | 50000.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| NATURE PHARMA NORGE AS | Active | 50.0% | 40000.000000 |
| LIFE LAB PHARMA AS | Active | 50.0% | 50000.000000 |
| NORWEGIAN SUPPLEMENTS INTERNATIONAL AS | Active | 50.0% | 15000.000000 |
| ALLVIA VITAL AS | Active | 33.3% | 100000.000000 |
| VITAE VITAL AS | Active | 4.0% | 980.000000 |
| MEDICAL DEVICE IMPORT AS | unknown | 2.9% | 1072.000000 |
| GLOBAL PHARMA GROUP AS | Active | 1.8% | 605000.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.